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Abstract 28 
Hepatitis B virus (HBV) X protein (HBx) plays an important role in HBV pathogenesis by 29 
regulating gene expression. Sterol regulatory element binding protein-1a (SREBP-1a) is a key 30 
transcriptional factor for modulating fatty acid and cholesterol synthesis. Here we demonstrated that HBx 31 
increased mature SREBP-1a protein level in the nucleus and its activity as a transcription factor. We 32 
further showed that the up-regulation of SREBP-1a by HBx occurred at the transcriptional level after 33 
ectopic expression and in the context of HBV replication. Deletional analysis using SREBP-1a promoter 34 
revealed that the sequence from -436 to -398 in the promoter was required for its activation by HBx. This 35 
promoter region possesses the binding sequences for two basic leucine zipper (b-ZIP) transcription 36 
factors, namely C/EBP and E4BP4. Mutagenesis of the binding sequences on the SREBP-1a promoter and 37 
ectopic expression experiments demonstrated that C/EBPα enhanced SREBP-1a activation by HBx, while 38 
E4BP4 had an inhibitory effect. C/EBPα was able to significantly reverse the inhibitory activity of E4BP4 39 
on SREBP-1a promoter. These results demonstrated that HBx activates SREBP-1a activity at the 40 
transcription level through a complex mechanism involving two bZIP transcription factors C/EBP and 41 
E4BP4 with C/EBP being the dominant positive factor. Finally, we showed that knocking down SREBP-1 42 
abolishes HBV enhancer II/core promoter activation by HBx.  43 
 44 
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1. Introduction 47 
Sterol regulatory element-binding proteins (SREBPs) belong to the family of basic-helix-loop-helix-48 
leucine zipper (bHLH-ZIP) transcription factors [11]. SREBPs directly activate the expression of 49 
numerous genes linked to the synthesis and uptake of cholesterol, fatty acids, triglycerides, and 50 
phospholipids. The mammalian genome encodes three SREBPs, designated SREBP-1a, SREBP-1c, and 51 
SREBP-2 [33]. In comparison to SREBP-1c, SREBP-1a has a longer transcription activation domain at its 52 
N-terminus which is capable of recruiting co-activators for transcription [33]. As such, SREBP-1a is a 53 
more potent activator of all SREBP-responsive genes for fatty acid and cholesterol synthesis, whereas 54 
SREBP-1c can only activate fatty acid synthesis [12;29]. SREBPs are synthesized as inactive precursors 55 
and the N-terminal portion, released from the SREBP precursor by proteolysis, enters the nucleus and 56 
becomes active transcriptional factors [3]. Nuclear SREBPs activate transcription by binding to SRE 57 
sequence in the promoter regions of target genes [11].  58 
Hepatitis B virus (HBV) infection is a global health problem with 350 to 400 million people being 59 
chronic carriers [2]. HBV has a partially double-stranded circular DNA genome coding for core, surface, 60 
polymerase, and the X (HBx) proteins [6]. Two viral enhancers promote HBV transcription [23]. 61 
Enhancer II/core promoter sequence regulates the transcription of 3.5-kb pregenomic RNA, a key step in 62 
HBV replication cycle. HBx increases HBV replication and activates HBV enhancer II/core promoter 63 
[5;15;21]. HBx also modulates host cellular functions including lipid metabolism [25;32]. In this study, 64 
we investigated activation of SREBP-1a by HBx and its involvement in regulating HBV enhancer II/core 65 
promoter by HBx.  66 
 67 
2. Materials and Methods 68 
2.1. Plasmids and antibodies  69 
The coding sequence of HBx was amplified by PCR from plasmids pRBK HBx or pawy1.2 [8;28] and 70 
cloned in-frame with the myc tag into the pEF/cyto/myc vector (Invitrogen). HBV enhancer II/core 71 
promoter sequence [27] was cloned into pGL4.14 vector (Promega), generating pGL4-HBV EN2/CP 72 
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where the expression of luciferase gene was controlled by HBV enhancer II/core promoter. Flag-tagged 73 
SREBP-1a (aa. 1-517) was amplified from an SREBP-1a plasmid [30] and inserted into the pCMV2 Flag 74 
vector (Sigma-Aldrich) [14]. Plasmid pSRE-Luc containing three copies of SRE sequences was provided 75 
by Dr. Shimano [1]. Human SREBP-1a promoter - luciferase reporters containing different lengths of the 76 
SREBP-1a promoter were described previously [10]. Mutant SREBP-1a promoters with mutations for the 77 
binding sequences for C/EBP (CCAAT/enhancer binding protein) and E4BP4 (Adenovirus E4 promoter 78 
binding protein 4) were generated by site-directed mutagenesis and confirmed by DNA sequencing 79 
(Figure 3). Plasmids expressing C/EBP [4] and E4BP4 (Open Biosystems) were used. SREBP-1-80 
targeting microRNA (miRNA) with target sequence of 5’ CCTGGTCTACCATAAGCTGCA 3’ was 81 
constructed in pcDNA6.2-GW/EmGFP miR vector (Invitrogen).   82 
SREBP-1, Flag (M2), fibrillarin, -actin and Myc epitope antibodies were from Santa Cruz 83 
Biotechnology, Sigma-Aldrich, and Cell Signaling Technology, respectively. Anti-HBx antibody was 84 
provided by Dr. Richardson [8].  85 
 86 
2.2. Cell culture, transfection and  nuclear fractionation  87 
Huh-7 cells [20] were maintained in Dulbecco’s modified Eagle’s medium (DMEM) with 10% (v/v) 88 
fetal bovine serum (FBS). Huh-7 cells were transfected using the calcium phosphate precipitation method 89 
as previously described [13]. Nuclear fractions were isolated as described [36]. 90 
 91 
2.3. Immunoblotting analysis  92 
Huh-7 cells were collected with a Cell Lysis Buffer (Cell Signaling Technology) containing 1 mM 93 
phenylmethylsulphonyl fluoride (PMSF). Immunoblotting was performed as described [14;36]. For 94 
SREBP experiments, cells were treated with a protease inhibitor ALLN (25 µg/ml, Calbiochem) for 1 95 
hour prior to lysis. 96 
 97 
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2.4. Reverse transcription and real-time PCR 98 
RNA was isolated from Huh-7 cells with Trizol (Invitrogen) followed by DNase I (Invitrogen) 99 
digestion. Reverse transcription was carried out by Superscript II (Invitrogen) and random priming. Real-100 
time PCR was performed with primers SREBP-1a-FD (5’ CGCTGCTGACCGACAT 3’) and SREBP-1a-101 
rev (5’ CAAGAGAGGAGCTCAATG 3’) using SYBR Green based detection system. Housekeeping 102 
gene GUSB was amplified in parallel by primers GUSB-FD (5’ GGTGCTGAGGATTGGCAGTG 3’) and 103 
GUSB-rev (5’ CGCACTTCCAACTTGAACAGG 3’). Data was analyzed by Bio-Rad iQ5 program. 104 
 105 
2.5. Luciferase assay  106 
Huh-7 cells were lysed in a Passive Lysis Buffer (Promega) and luciferase activity was determined 107 
using luciferase assay reagents (Promega) in a TD 20/20 Luminometer (Turner Designs). Results were 108 
analyzed for statistical differences using Student t test.  A p value of  0.05 was considered statistically 109 
significant. 110 
 111 
3. Results 112 
3.1. HBx increases the level of SREBP-1a in the nucleus 113 
HBx coding sequence was cloned into the pEF-cyto-myc vector in-frame with the myc tag. The 114 
resulting plasmid was transfected into Huh-7 cells and the cell lysates were analyzed in immunoblotting. 115 
As shown in Fig. 1A, a specific protein band was recognized by an HBx-specific antibody and a myc-tag 116 
antibody (not shown) in cells transfected with HBx-expressing plasmid, but not in vector-transfected cells. 117 
The level of β-actin was used as loading control. These results demonstrated the expression of HBx 118 
protein after transfection.  119 
Given the importance of SREBP-1a in modulating lipid metabolism, we explored the role of HBx in 120 
SREBP-1a activation. Huh-7 cells were transfected with HBx-expressing plasmid and vector control. The 121 
level of SREBP-1 was analyzed by immunoblotting using an anti-SREBP-1 antibody. As shown in the 122 
  
[Type text] 
 
upper panel of Fig. 1A, expression of HBx was associated with increased level of SREBP-1 compared to 123 
control. Because we were interested in SREBP-1a levels especially in the nucleus as the active form, 124 
however the SREBP-1 antibody cannot distinguish SREBP-1a from another isoform SREBP-1c. 125 
Therefore we used a plasmid expressing Flag-tagged SREBP-1a and an anti-Flag antibody to examine 126 
nuclear SREBP-1a levels (lower panel of Fig. 1A). The results showed that the nuclear SREBP-1a protein 127 
level was increased in HBx transfected cells than in vector transfected cells. To determine whether the 128 
increased SREBP-1a correlates with its enhanced activity as a transcription factor, we used an SRE-129 
luciferase reporter where the luciferase expression is directly controlled by three copies of SRE sequences 130 
(ATCACCCCAC, pSRE-Luc) [1]. This is because SREBP-1a activates transcription of its target genes by 131 
binding to the SRE sequence. As shown in Fig. 1B, HBx expression significantly increased SRE-driven 132 
luciferase activity by SREBP-1a compared to control. These results indicate that expression of HBx 133 
increases SREBP-1a level in the nucleus and its transcription factor activity.  134 
 135 
3.2. HBx activates SREBP-1a transcription  136 
      SREBPs are often regulated at the transcription level. To determine whether HBx regulates SREBP-1a 137 
transcription, we measured the level of SREBP-1a transcript by real-time PCR after HBx expression in 138 
Huh-7 cells. As shown in Fig. 2A, HBx expression resulted in more than 2-fold increase in SREBP-1a 139 
transcript level in comparison to control. A greater than one genome length HBV plasmid is a widely used 140 
model for HBV. As such, we transfected HBV wild-type genome (pawy1.2) and HBV without HBx 141 
(pawy1.2*7) [28] into Huh-7 cells and determined SREBP-1a transcript levels. As shown in Fig. 2B, 142 
SREBP-1a transcript level in HBV-transfected cells were significantly higher than those in vector- or 143 
HBV ∆HBx-transfected cells. The expression of HBx was confirmed after HBV plasmid transfection, 144 
whereas no HBx could be detected in vector- or HBV∆HBx-transfected cells (Fig. 2C). These results 145 
indicate that HBx up-regulates SREBP-1a transcription. 146 
To further characterize SREBP-1a transcription up-regulation by HBx, Huh-7 cells were co-147 
transfected with a luciferase reporter under the control of human SREBP-1a promoter (-1008) [10] and 148 
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increasing amounts of HBx-expressing plasmid. The total amounts of plasmid DNA used for transfection 149 
were kept constant by adding appropriate amounts of the vector plasmid. Luciferase assay showed that 150 
HBx significantly activated SREBP-1a promoter activity in a dose-dependent manner in comparison to 151 
vector control (Fig. 2D). Similarly, HBV plasmid transfection resulted in significantly higher luciferase 152 
activity than vector- or HBV∆HBx-transfection (Fig. 2E).   153 
       Next, we wanted to map the regions on the SREBP-1a promoter that were required for its activation 154 
by HBx. We used five truncated SREBP-1a promoters -889, -717, -436, -398, and -360 (Fig. 3A). 155 
Luciferase assay results showed that deletion from -1008 to -436 in the SREBP-1a promoter did not affect 156 
its activation by HBx, whereas the activation was abolished when the -398 and -360 promoters were used. 157 
These results indicate that the sequence between -436 and -398 in the SREBP-1a promoter is required for 158 
its activation by HBx.  159 
 160 
      3.3. Effects of C/EBP and E4BP4 on SREBP-1a regulation by HBx 161 
      Sequence analysis by the MatINSPECTOR prediction program indicated that the -436 to -398 region 162 
in the SREBP-1a promoter contains binding motifs for transcription factors C/EBP and E4BP4 (Fig. 3B). 163 
To gain the first insights into the role of these two factors in SREBP-1a regulation by HBx, we mutated 164 
the binding sequences for each of the factors in the SREBP-1a promoter (Fig. 3C). These mutant SREBP-165 
1a promoters were used in co-transfection experiments to test their activity after HBx expression. As 166 
shown in Fig. 3C, HBx failed to activate these mutant SREBP-1a promoters. These results suggested that 167 
the integrity of C/EBP and E4BP4 binding sequences is necessary for SREBP-1a regulation by HBx. 168 
Previous research has established that C/EBP and E4BP4 have divergent effects on transcription, although 169 
both belong to a family of basic leucine zipper (bZIP) proteins [7;34].  170 
To determine the effects of these transcription factors in SREBP-1a regulation by HBx, we 171 
studied SREBP-1a promoter activity after ectopic expression of C/EBPα or E4BP4. There are six isoforms 172 
in the C/EBP family and C/EBPα was isolated from the liver [31;34]. Therefore, we used a plasmid 173 
expressing C/EBPα. As shown in Fig. 3D, transfection with increasing amounts of C/EBPα resulted in 174 
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dose-dependent SREBP-1a promoter activation in both vector and HBx expressing cells. In contrast, 175 
increasing amounts of E4BP4 resulted in dose-dependent decrease in SREBP-1a promoter activity in both 176 
vector and HBx expressing cells (Figs. 3E). These results indicated that C/EBPα is as an activator, 177 
whereas E4BP4 is a repressor for SREBP-1a promoter regulation by HBx.  178 
Opposing effects of C/EBP and E4BP4 on SREBP-1a promoter regulation by HBx raised a 179 
question as to whether the inhibitory effect of E4BP4 can be overcome by C/EBP. To answer this question, 180 
Huh-7 cells were co-transfected with HBx-expressing plasmid and SREBP-1a promoter (-436) - luciferase 181 
reporter, together with E4BP4 alone or with C/EBPα. Corresponding vectors were used as controls. As 182 
shown in Fig. 3F, the inhibition of SREBP-1a promoter activity by E4BP4 was significantly reversed 183 
upon ectopic expression of C/EBPα E4BP4. These results suggest that C/EBPα has a dominantly 184 
activating effect on SREBP-1a promoter activity. 185 
 186 
3.4. Effect of SREBP-1 in HBV enhancer II/core promoter activation by HBx 187 
Our results so far have shown that HBx activates SREBP-1a. Previous studies demonstrated that HBx 188 
increases HBV enhancer II/core promoter activity [5;15]. We therefore interested in determining whether 189 
SREBP-1a is involved in this process. For this purpose, we used a miRNA to knockdown SREBP-1 190 
expression in Huh-7 cells. As shown in Fig. 4A, the levels of both precursor and mature SREBP-1 191 
proteins were reduced by SREBP-1 miRNA in comparison to control miRNA. When Huh-7 cells were 192 
transfected with vector or HBx-expressing plasmids together with pGL4-HBV EN2/CP, modest but 193 
significant 1.5-fold transactivation of enhancer II/core promoter by HBx was observed (Fig. 4B). This 194 
result is consistent with other studies showing activation of enhancer II/core promoter by HBx [5;15]. 195 
Upon knockdown SREBP-1, HBx was no longer able to transactivate enhancer II/core promoter (Fig. 4C). 196 
These results demonstrate that SREBP-1 is involved in HBV enhancer II/core promoter transactivation by 197 
HBx. 198 
     199 
4. Discussion 200 
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HBx is a multifunctional protein. Here, we demonstrated that HBx activates SREBP-1a, a 201 
transcription factor involved in several (patho)-physiological conditions such as lipogenesis and 202 
carcinogenesis [18;19]. We further demonstrated that SREBP-1 is involved in HBV enhancer II/core 203 
promoter activation by HBx.  204 
To become an active transcription factor, SREBP-1a needs to enter the nucleus and therefore nuclear 205 
SREBP-1a level reflects its activity. As such, we first demonstrated that HBx expression is associated 206 
with increased level of SREBP-1a in the nucleus (Fig. 1A). An SRE-driven luciferase reporter assay 207 
confirmed that SREBP-1a in HBx-transfected cells is indeed transcriptionally active (Fig. 1B). 208 
The expression of SREBP-1a can be regulated at the transcription level [10]. Our results demonstrated 209 
that HBx can significantly up-regulate the activity of SREBP-1a promoter in a dose-dependent manner 210 
(Fig. 2D). More importantly, we showed that HBx in the context of HBV can also transactivate SREBP-1a 211 
transcription using a plasmid-based HBV model (Figs. 2B and 2E). Mapping the sequences in the SREBP-212 
1a promoter required for activation by HBx led us to concentrate on two bZIP transcription factors, 213 
namely C/EBP and E4BP4. Mutating the C/EBP binding sequence on the SREBP-1a promoter canceled 214 
SREBP-1a promoter activation by HBx (Fig. 3C). Consistently, ectopic expression of C/EBPα 215 
demonstrated that it can further enhance SREBP-1a promoter activation by HBx (Fig. 3D). These results 216 
suggest that C/EBP is required for SREBP-1a activation by HBx.   217 
Ectopic expression of E4BP4, on the other hand, has an opposing, inhibiting effect on SREBP-1a 218 
promoter activity (Fig. 3E). This finding is consistent with the established repressor activity of E4BP4 on 219 
transcription [7]. However, when the E4BP4 binding sequence was mutated on the SREBP-1a promoter, 220 
we did not see the expected increase of the promoter activity (Fig. 3C). The underlying reason is not clear. 221 
Several possible mechanisms exist. The binding sequences on gene promoters for bZIP transcription 222 
factors are similar, which may result in DNA binding competition by these factors [7]. In fact, it has been 223 
shown that C/EBP and E4BP4 can compete with each other in DNA binding and regulate transcription in 224 
a competitive manner [22;26]. Therefore, we cannot exclude the possibility that C/EBP can also bind the 225 
E4BP4 sequence on SREBP-1a promoter and positively regulate its activity. As such, elimination of 226 
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E4BP4 binding sequence can potentially affect the activities of both E4BP4 and C/EBP. Another 227 
possibility is that mutating the E4BP4 binding motif might somehow negatively affect the binding of 228 
C/EBP to its recognition sequence on the SREBP-1a promoter because they are in a very close proximity. 229 
In addition, b-ZIP factors regulate transcription by forming homo- and/or hetero-dimers [9]. According to 230 
a molecular interaction model, C/EBP and E4BP4 may interact with each other due to the presence of an 231 
asparagine residue in the “a” position of their bZIP domains which would favor heterodimerization [35]. It 232 
is reasonable to assume that elimination of E4BP4 binding sequence on the SREBP-1a promoter may 233 
increase the amount of free E4BP4. Then it is possible that more E4BP4 proteins can interact with C/EBP 234 
and interfere with the activity of C/EBP, resulting in reduced SREBP-1a promoter activation. If this is true, 235 
one would expect that increasing the amount of C/EBP should increase SREBP-1a promoter activity in the 236 
presence of E4BP4. This has been actually observed in our experiments (Fig. 3F). However, the exact 237 
mechanisms warrant further investigation.   238 
Recent studies have shown that HBx can activate SREBP-1c, the other isoform of SREBP-1, through 239 
liver X receptor [16;17;24]. Adding to these previous findings, our study has demonstrated that HBx can 240 
also activate SREBP-1a through a different and complex mechanism involving at least two transcription 241 
factors, C/EBP and E4BP4. More importantly, SREBP-1a is a more potent transcription activator for both 242 
fatty acid and cholesterol synthesis pathways [12;29;33]. In contrast, SREBP-1c is less active and only 243 
activates fatty acid synthesis. The functional significance of SREBP-1 activation in HBV biology and 244 
pathogenesis has not been characterized. Towards this goal, we showed that knocking down SREBP-1 245 
abolishes activation of HBV enhancer II/core promoter activation by HBx (Fig. 4). Since the miRNA 246 
sequence we used does not distinguish between SREBP-1a and -1c, further experiments are needed to 247 
determine isoform-specific effects of SREBP-1.  248 
In conclusion, our results demonstrated that HBx activates the SREBP-1a activity by a complex 249 
mechanism involving two bZIP transcription factors C/EBP and E4BP4 with the former being the 250 
dominant factor leading to SREBP-1a promoter activation. Furthermore, we showed that SREBP-1 is 251 
involved in HBV enhancer II/core promoter activation by HBx.   252 
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Figure Legends 261 
 262 
Figure 1. Expression of HBx increases the level of nuclear SREBP-1a and its transactivation 263 
activity. (A). In the top panel, the levels of HBx, SREBP-1, and β-actin in Huh-7 cells after 264 
transfection with an HBx-expressing plasmid or the vector were analyzed by immunoblotting. In 265 
the bottom panel, levels of SREBP-1a in the nuclear fraction were analyzed by immunoblotting 266 
after co-transfection with plasmids expressing Flag-SREBP-1a and HBx or vector. The blots were 267 
probed with antibodies against Flag-tag or fibrillarin. (B). A luciferase reporter driven by SRE 268 
sequences was co-transfected with a plasmid encoding Flag-SREBP-1a together with HBx-269 
expressing plasmid or vector control into Huh-7 cells. Luciferase assay was performed using the 270 
cell lysates. Luciferase activity was expressed as fold change relative to vector control. The 271 
statistical difference between samples was demonstrated as ** if p ≤ 0.01.   272 
 273 
Figure 2.  HBx up-regulates SREBP-1a transcription. (A, B). Huh-7 cells were transfected with 274 
vector or HBx-expressing plasmids (A), vector, HBV, or HBV ∆HBx (B). The levels of SREBP-275 
1a transcript were analyzed by reverse-transcription real-time PCR. (C). The protein levels of 276 
HBx and β-actin in Huh-7 cells after transfection with vector, HBV, or HBV ∆HBx were 277 
determined by immunoblotting. (D, E). Huh-7 cells were co-transfected with a human SREBP-1a 278 
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promoter (-1008/+194)-luciferase reporter plasmid with increasing amounts of HBx-expressing 279 
plasmid (D) or vector, HBV, or HBV ∆HBx (E). Luciferase activities were expressed as fold 280 
changes relative to vector control. The statistical differences between samples were demonstrated 281 
as NS for not significant, * if p ≤ 0.05, or *** if p ≤ 0.001. 282 
 283 
Figure 3. The roles of transcription factors C/EBP and E4BP4 in SREBP-1a promoter regulation 284 
by HBx. (A). Huh-7 cells were transfected with SREBP-1a promoters of different lengths 285 
together with HBx-expressing plasmid or vector control. SREBP-1a promoter activity was 286 
determined by luciferase assay. (B). SREBP-1a promoter sequence -436 to -397. The binding 287 
motifs as well as the mutated sequences for C/EBP and E4BP4 are shown. (C). Sequence 288 
integrity of the SREBP-1a promoter -436 to -398 region is required for its activation by HBx. 289 
Huh-7 cells were co-transfected with wild-type or mutant SREBP-1a promoters with HBx-290 
expressing plasmid or vector control. SREBP-1a promoter activity was determined by luciferase 291 
assay. (D, E). Huh-7 cells were co-transfected with SREBP-1a-promoter luciferase reporter (-292 
436/+194), HBx-expressing plasmid or vector control, together with increasing amounts of 293 
C/EBPα (D) or E4BP4 (E). SREBP-1a promoter activity was determined by luciferase assay. (F). 294 
Huh-7 cells were co-transfected with SREBP-1a-promoter luciferase reporter (-436/+194), HBx-295 
expressing plasmid, together with vector, E4BP4-expressing plasmid, and C/EBPα-expressing 296 
plasmid. SREBP-1a promoter activity was determined by luciferase assay. The statistical 297 
differences between samples were demonstrated as NS for not significant, * if p ≤ 0.05, ** if p 298 
≤ 0.01, or *** if p ≤ 0.001. 299 
 300 
Figure 4. The role of SREBP-1 in HBV enhancer II/core promoter activation by HBx. (A). Huh-7 301 
cells were transfected with control or SREBP-1 miRNAs. The levels of precursor and mature 302 
SREBP-1 were determined by immunoblotting. (B). Huh-7 cells were co-transfected with HBV 303 
enhancer II/core promoter-luciferase reporter pGL4 HBV EN2/CP and vector or HBx-expressing 304 
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plasmids. Luciferase activities after HBx expression were expressed as fold changes relative to 305 
vector control. (C). Huh-7 cells were co-transfected with pGL4 HBV EN2/CP, HBx-expressing 306 
plasmid, and control or SREBP-1 miRNA. Luciferase activities after SREBP-1 knockdown were 307 
expressed as fold changes relative to control miRNA-transfection. The statistical differences 308 
between samples were demonstrated as * if p ≤ 0.05. 309 
 310 
 311 
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